IRS-1 interacts with the catalytic p110 subunit, leading to increased PIP3 and p85 regulatory subunit sequestration, which is associated with increased insulin resistance and can explain the side effects of PIK3CA inhibitors, such as hyperglycemia. The gene discussed is PIK3CA; the disease is Hyperglycemia.